{
  "id": 1730,
  "text": "These doses were equivalent to cisplatin doses of 75 to $1 0 0 ~ \\mathrm { m g / m ^ { 2 } }$ .Although this RCT was not designed to compare either analog with cisplatin, the authors noted that overall response rates and complete response rates for both carboplatin and iproplatin were not superior and possibly inferior to those previously reported for the parent, cisplatin.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: These doses were equivalent to cisplatin doses of 75 to $1 0 0 ~ \\mathrm { m g / m ^ { 2 } }$ .Although this RCT was not designed to compare either analog with cisplatin, the authors noted that overall response rates and complete response rates for both carboplatin and iproplatin were not superior and possibly inferior to those previously reported for the parent, cisplatin.\n\n<question>: ",
  "ChatGPT_response_0": "未来的类铂类药物研究可能需要更加深入地探究其相对于顺铂的疗效和安全性表现。鉴于该研究发现卡铂和伊普铂的总体反应率和完全缓解率可能不如顺铂，未来的研究可以考虑进一步比较不同类铂类药物在治疗特定疾病方面的效果。此外，研究人员还可以在研究设计中更好地控制变量，确保比较的公正性和科学性，从而更准确地评估不同类铂类药物的疗效。继续深入了解不同类铂类药物的药理特点和作用机制也是未来研究的重点之一，以期望为患者提供更好的治疗选择。",
  "query": "这些剂量相当于75到100毫克/平方米的顺铂剂量。尽管这个随机对照试验没有旨在比较类铂类药物与顺铂，但作者指出，卡铂和伊普铂的总体反应率和完全缓解率可能不如以前报道的母药顺铂。你认为这种情况对于未来的类铂类药物研究会有什么启示？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 这些剂量相当于75到100毫克/平方米的顺铂剂量。尽管这个随机对照试验没有旨在比较类铂类药物与顺铂，但作者指出，卡铂和伊普铂的总体反应率和完全缓解率可能不如以前报道的母药顺铂。你认为这种情况对于未来的类铂类药物研究会有什么启示？\n\n<reference text>: These doses were equivalent to cisplatin doses of 75 to $1 0 0 ~ \\mathrm { m g / m ^ { 2 } }$ .Although this RCT was not designed to compare either analog with cisplatin, the authors noted that overall response rates and complete response rates for both carboplatin and iproplatin were not superior and possibly inferior to those previously reported for the parent, cisplatin.\n\n<reply>: ",
  "response": "未来的类铂类药物研究可能需要更加深入地探究其相对于顺铂的疗效和安全性表现。鉴于该研究发现卡铂和伊普铂的总体反应率和完全缓解率可能不如顺铂，未来的研究可以考虑进一步比较不同类铂类药物在治疗特定疾病方面的效果。此外，研究人员还可以在研究设计中更好地控制变量，确保比较的公正性和科学性，从而更准确地评估不同类铂类药物的疗效。继续深入了解不同类铂类药物的药理特点和作用机制也是未来研究的重点之一，以期望为患者提供更好的治疗选择。"
}